Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HempWire is a specialized communications and digital media platform focused on the hemp and CBD industries. As a brand under the InvestorBrandNetwork (IBN), the company provides corporate communications, content syndication, and investor relations services to both public and private entities. HempWire leverages a distribution network of over 5,000 key syndication outlets to enhance brand visibility and market reach for its clients. The platform serves as a central hub for news, articles, and updates regarding regulatory changes and market trends within the hemp sector. While it operates within the broader wellness and life sciences ecosystem, HempWire does not develop its own therapeutic products or conduct clinical research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hempwire.